BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Slotta JE, Kollmar O, Ellenrieder V, Ghadimi BM, Homayounfar K. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World J Hepatol 2015; 7(9): 1168-1183 [PMID: 26019733 DOI: 10.4254/wjh.v7.i9.1168]
URL: https://www.wjgnet.com/1948-5182/full/v7/i9/1168.htm
Number Citing Articles
1
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären KarzinomDer Chirurg 2020; 91(9): 769 doi: 10.1007/s00104-020-01118-6
2
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and howWorld Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
3
ZHICHENG YAO, KUNPENG HU, HE HUANG, SHILEI XU, QINGLIANG WANG, PENG ZHANG, PEISHENG YANG, BO LIU. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferationInternational Journal of Molecular Medicine 2015; 36(5): 1393 doi: 10.3892/ijmm.2015.2350
4
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapyJournal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
5
Antonio Giorgio, Maria G Merola, Luca Montesarchio, Francesca Merola, Pietro Gatti, Carmine Coppola, Valentina Giorgio, Giorgio Calisti. Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 yearsThe British Journal of Radiology 2017; 90(1074): 20160804 doi: 10.1259/bjr.20160804
6
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations World Journal of Clinical Cases 2023; 11(8): 1753-1760 doi: 10.12998/wjcc.v11.i8.1753
7
A. Bauschke, A. Altendorf-Hofmann, C. Malessa, S. Schüle, J. Zanow, U. Settmacher. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?Journal of Cancer Research and Clinical Oncology 2016; 142(12): 2593 doi: 10.1007/s00432-016-2260-y
8
Michihiro Kudou, Atsushi Shiozaki, Toshiyuki Kosuga, Hiroki Shimizu, Daisuke Ichikawa, Hirotaka Konishi, Ryo Morimura, Shuhei Komatsu, Hisashi Ikoma, Hitoshi Fujiwara, Kazuma Okamoto, Yoshinori Marunaka, Eigo Otsuji. Heat shock exerts anticancer effects on liver cancer via autophagic degradation of aquaporin 5International Journal of Oncology 2017; 50(5): 1857 doi: 10.3892/ijo.2017.3940
9
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhäuser, Tomasz P. Rygiel. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment OptionsInternational Journal of Molecular Sciences 2022; 23(7): 3778 doi: 10.3390/ijms23073778
10
Teodora Surdea-Blaga, Roxana L. Cărăguț, Cosmin Caraiani, Zeno Spârchez, Nadim al Hajjar, Dan L. Dumitrașcu. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case reportJournal of Medical Case Reports 2023; 17(1) doi: 10.1186/s13256-023-03932-y
11
Hyosun Tak, Hoin Kang, Eunbyul Ji, Youlim Hong, Wook Kim, Eun Kyung Lee. Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinomaBiochemical and Biophysical Research Communications 2018; 497(4): 1117 doi: 10.1016/j.bbrc.2018.02.189
12
Zaixiong Ji, Jiaqi Li, Jianbo Wang. Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinomaHereditas 2021; 158(1) doi: 10.1186/s41065-021-00179-9
13
Jingyao Hu, Liang Yang, Xueqiang Peng, Minghuan Mao, Xiaodan Liu, Jianbo Song, Hangyu Li, Fu Chen. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinomaHuman Cell 2022; 35(6): 1838 doi: 10.1007/s13577-022-00769-3
14
Yanxia Gong, Jie Zhang, Xiang Wu, Tao Wang, Jia Zhao, Zhi Yao, Qingyu Zhang, Xi Liu, Xu Jian. Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapyOncology Letters 2017; 14(4): 4158 doi: 10.3892/ol.2017.6724
15
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
16
Ningning Liu, Xiaomei Wang, Clifford John Steer, Guisheng Song. MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cellsGut 2021; : gutjnl-2021-324170 doi: 10.1136/gutjnl-2021-324170
17
Junjie Hu, Ningning Liu, David Song, Clifford J. Steer, Guohua Zheng, Guisheng Song. A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinomaOncogene 2023; 42(39): 2892 doi: 10.1038/s41388-023-02757-9
18
Ningning Liu, Ching Wen Chang, Clifford J. Steer, Xin Wei Wang, Guisheng Song. MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T CellsGastroenterology 2022; 162(2): 575 doi: 10.1053/j.gastro.2021.10.015
19
Tonghai Xing, Tingmang Yan, Qiang Zhou. Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysisExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6075
20
Sebastian Lünse, Claus-Dieter Heidecke, Lars Ivo Partecke. Hepatocellular Carcinoma2019; : 111 doi: 10.15586/hepatocellularcarcinoma.2019.ch6
21
Xiao-Bo Lai, Yu-Qiang Nie, Hong-Li Huang, Ying-Fei Li, Chuang-Yu Cao, Hui Yang, Bo Shen, Zhi-Qiang Feng. NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferationOncology Letters 2017; 13(3): 1587 doi: 10.3892/ol.2017.5618
22
Heng Wu, Junyan Tao, Xiaolei Li, Tianpeng Zhang, Lei Zhao, Yao Wang, Lei Zhang, Jun Xiong, Zhi Zeng, Na Zhan, Clifford J. Steer, Li Che, Mingjie Dong, Xiaomei Wang, Junqi Niu, Zhuoyu Li, Guiqing Yan, Xin Chen, Guisheng Song. MicroRNA‐206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto‐oncogene and cyclin‐dependent kinase 6 in miceHepatology 2017; 66(6): 1952 doi: 10.1002/hep.29374
23
Bashan Zhang, Fei Li, Zinian Zhu, Aijiao Ding, Jintong Luo. <p>CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway</p>Cancer Management and Research 2020; : 8951 doi: 10.2147/CMAR.S252679
24
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Agustín F. González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A. Barrera. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantationExpert Review of Molecular Diagnostics 2019; 19(7): 635 doi: 10.1080/14737159.2019.1619549
25
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantationWorld Journal of Hepatology 2022; 14(6): 1182-1189 doi: 10.4254/wjh.v14.i6.1182
26
Dalia A. Gaber, Olfat Shaker, Alaa Tarek Younis, Mohamed El-Kassas. LncRNA HULC and miR-122 Expression Pattern in HCC-Related HCV Egyptian PatientsGenes 2022; 13(9): 1669 doi: 10.3390/genes13091669
27
Xinyan Chen, Xianxian Hu, Junjie Hu, Zhenpeng Qiu, Ming Yuan, Guohua Zheng. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in MiceMolecular Pharmaceutics 2020; 17(3): 738 doi: 10.1021/acs.molpharmaceut.9b00428
28
Sidra Altaf, Faiza Saleem, Azam Ali Sher, Ashiq Ali. Potential Therapeutic Strategies to Combat HCCCurrent Molecular Pharmacology 2022; 15(7): 929 doi: 10.2174/1874467215666220103111009
29
Eman K. A. Abdelall, Heba A. H. Elshemy, Madlen B. Labib, Fatma E. A. Mohamed. Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibitionDrug Development Research 2024; 85(1) doi: 10.1002/ddr.22133
30
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Dácil Díaz, Antonia Moreno, Elisa Borja, María Martín, Alejandro Jiménez, Manuel Barrera. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2016; 17(4): 500 doi: 10.3390/ijms17040500
31
Daoyan Wei, Dongmei Chen, Hongyuan Mou, Sharmistha Chakraborty, Bo Wei, Lin Tan, Philip L. Lorenzi, Xiangping Qian, Peiying Yang. Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular CarcinomaMolecular Cancer Therapeutics 2023; 22(6): 693 doi: 10.1158/1535-7163.MCT-22-0490
32
Jixiong Hu, Weidong Dai, Chun Liu, Tenglong Tang. Atlas of Anatomic Hepatic Resection for Hepatocellular Carcinoma2019; : 261 doi: 10.1007/978-981-13-0668-6_5
33
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Agustín González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel Barrera. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver TransplantationInternational Journal of Molecular Sciences 2019; 20(7): 1696 doi: 10.3390/ijms20071696
34
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi ArabiaJournal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
35
Hengjing He, Muhammad Jamal, Xingruo Zeng, Yufei Lei, Di Xiao, Zimeng Wei, Chengjie Zhang, Xiaoyu Zhang, Shan Pan, Qianshan Ding, Haiyan Tan, Songping Xie, Qiuping Zhang. Matrin-3 acts as a potential biomarker and promotes hepatocellular carcinoma progression by interacting with cell cycle-regulating genesCell Cycle 2024; : 1 doi: 10.1080/15384101.2024.2305535
36
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
37
Jasem Albarrak, Humaid Al-Shamsi. Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and RecommendationsCancers 2023; 15(7): 2001 doi: 10.3390/cancers15072001